Aggravation of airway inflammation and hyper-responsiveness following nasal challenge with Dermatophagoides pteronyssinus in perennial allergic rhinitis without symptoms of asthma

被引:26
|
作者
Wang, W. [1 ]
Xian, M. [1 ]
Xie, Y. [1 ]
Zheng, J. [1 ]
Li, J. [1 ,2 ]
机构
[1] Guangzhou Med Univ, Affiliated Hosp 1, Dept Allergy & Clin Immunol, State Key Lab Resp Dis, Guangzhou 510120, Guangdong, Peoples R China
[2] Guangzhou Med Univ, Guangdong Prov Key Lab Allergy & Clin Immunol, Guangzhou 510120, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
airway hyper-responsiveness; allergic rhinitis; Dermatophagoides pteronyssinus; eosinophils; nasal provocation test; HOUSE-DUST MITE; PROVOCATION TEST; AND/OR RHINITIS; POSITION PAPER; SENSITIZATIONS; ASSOCIATION; EXPOSURE; STANDARD; CHILDREN; LUNG;
D O I
10.1111/all.12808
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
BackgroundHouse dust mites are the most prevalent allergen causing sensitizations in patients with rhinitis and asthma in China. We aimed to investigate the changes in both upper and lower airway inflammation and responsiveness following Dermatophagoides pteronyssinus (Der-p) nasal provocation test (NPT) in rhinitis patients. MethodsStudy subjects included 15 nonasthmatic Der-p-sensitized rhinitis (AR) patients with airway hyper-responsiveness (AHR) (AR+AHR+), 15 AR patients without AHR (AR+AHR-), 15 healthy controls (HCs) with Der-p sensitization (HC+DP+), and 15 HC without Der-p sensitization (HC+DP-). All subjects underwent Der-p NPT. Visual analogue scale (VAS) scores of nasal symptoms, nasal lavage and nasal airway resistance (NAR) measurement, sputum induction, and forced expiratory volume in 1 second (FEV1) were performed. Airway responsiveness to histamine bronchoprovocation (PD20-FEV1) and exhaled nitric oxide (FeNO) was determined. ResultsNAR increased significantly in all subjects with the greatest effect seen in AR+AHR+ individuals. VAS increased in all subjects at 30 min and returned to baseline at 6 h, with significantly higher levels in AR+AHR+ and AR+AHR- subjects (P < 0.05). Eosinophils in nasal lavage fluid and sputum increased significantly after NPT in AR+AHR+ and AR+AHR- subjects (P < 0.001). FEV1% and PD20-FEV1 decreased and FeNO increased significantly after NPT only in AR+AHR+ subjects (P < 0.05). Nasal lavage eosinophil count was positively correlated with sputum eosinophil count and the level of FeNO and negatively correlated with FEV1 and PD20. ConclusionsHouse dust mite nasal provocation test induces and aggravates both upper and lower airway inflammation and hyper-responsiveness in patients with persistent allergic rhinitis without asthmatic symptoms.
引用
收藏
页码:378 / 386
页数:9
相关论文
共 33 条
  • [21] Effects of leukotriene D4 nasal challenge on bronchial responsiveness and inflammation in asthmatic patients with allergic rhinitis
    Zhu, Zheng
    Xie, Yanqing
    Guan, Weijie
    Gao, Yi
    Huang, Rongquan
    Xia, Shu
    Jian, Wenhua
    Liang, Zhiyu
    Zheng, Jinping
    JOURNAL OF THORACIC DISEASE, 2017, 9 (02) : 271 - 277
  • [22] Mycobacterium vaccae alleviates allergic airway inflammation and airway hyper-responsiveness in asthmatic mice by altering intestinal microbiota
    Xiao, Huan
    Fang, Li-ting
    Tang, An-zhou
    Chen, Hong-liu
    Xu, Mei-li
    Wei, Xiao-shua
    Pang, Guo-dong
    Li, Chao-qian
    IMMUNOLOGY, 2024, 171 (04) : 595 - 608
  • [23] Desloratadine reduces systemic allergic inflammation following nasal provocation in allergic rhinitis and asthma patients
    Reinartz, SM
    Overbeek, SE
    KleinJan, A
    van Drunen, CM
    Braunstahl, GJ
    Hoogsteden, HC
    Fokkens, WJ
    ALLERGY, 2005, 60 (10) : 1301 - 1307
  • [24] Antigen-induced airway inflammation and hyper-responsiveness does not enhance airway responses to a subsequent antigen challenge in rats
    Laberge, S
    Rossi, P
    Yang, XX
    Martin, JG
    RESPIRATORY MEDICINE, 2000, 94 (01) : 44 - 50
  • [25] Respiratory symptoms, bronchial hyper-responsiveness, and eosinophilic airway inflammation in patients with moderate-to-severe atopic dermatitis
    Kyllönen, H
    Malmberg, P
    Remitz, A
    Rytilä, P
    Metso, T
    Helenius, I
    Haahtela, T
    Reitamo, S
    CLINICAL AND EXPERIMENTAL ALLERGY, 2006, 36 (02) : 192 - 197
  • [26] SRS27,a semisynthetic diterpenoid lactone,inhibits airway inflammation and hyper-responsiveness via NF-κB pathway in an allergic mouse asthma model
    Jonathan Chee Woei LIM
    Fera Yiqian GOH
    Sreenivasa Rao SAGINEEDU
    Audrey Chee Hui YONG
    Shiran Mohd SIDIK
    Nordin Haji LAJIS
    Wai-Shiu Fred WONG
    Johnson STANSLAS
    中国药理学与毒理学杂志, 2015, 29(S1) (S1) : 53 - 53
  • [27] Effect of intranasal triamcinolone acetonide on bronchial hyper-responsiveness in children with seasonal allergic rhinitis and comparison of perceptional nasal obstruction with acoustic rhinometric assessment
    Öztürk, F
    Türktas, I
    Asal, K
    Ileri, F
    Pinar, NM
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2004, 68 (08) : 1007 - 1015
  • [28] Inhaled corticosteroids improve lung function, airway hyper-responsiveness and airway inflammation but not symptom control in patients with mild intermittent asthma: A meta-analysis
    Du, Wei
    Zhou, Ling
    Ni, Yingmeng
    Yu, Yuanyuan
    Wu, Fang
    Shi, Guochao
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (02) : 1594 - 1608
  • [29] Ingestion of milk containing the Dp2 peptide, a dust mite allergen, protects mice from allergic airway inflammation and hyper-responsiveness
    Liu, Hsu-Chung
    Pai, Shun-Yuan
    Cheng, Winston T. K.
    Chen, Hsiao-Ling
    Tsai, Tung-Chou
    Yang, Shang-Hsun
    Chen, Chuan-Mu
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2013, 9
  • [30] Extracts of Phlomoides umbrosa Turczaninow alleviate allergic airway inflammation in lipopolysaccharide-stimulated RAW 264.7 cells and ovalbumin-induced hyper-responsiveness mouse model
    Jang, Se-Won
    Jo, Ha-Neul
    Han, Yoon-Young
    Lee, Jae-Sun
    Kim, Bo-Mi
    Kim, Ji-Min
    Lee, Yong-Wook
    Park, Chan-Sung
    Lee, Dae-Young
    Kim, Kwan-Woo
    Lee, Young-Seob
    FOOD SCIENCE AND BIOTECHNOLOGY, 2024, 33 (11) : 2611 - 2621